Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

被引:7
|
作者
Gong, Dengmei [1 ]
Adomako-Bonsu, Amma G. [2 ]
Wang, Maijian [3 ]
Li, Jida [1 ]
机构
[1] Zunyi Med Univ, Coll Publ Hlth, Inst Zoonosis, Zunyi, Guizhou, Peoples R China
[2] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol, Kiel, Germany
[3] Zunyi Med Univ, Affiliate Hosp, Gastrointestinal Surg, Zunyi, Guizhou, Peoples R China
来源
PEERJ | 2023年 / 11卷
关键词
Gut microbiota; Enterotoxigenic Bacteroides fragilis; Genotoxic Escherichia coli; Fusobacterium nucleatum; COLON-TUMOR GROWTH; GERM-FREE RATS; FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; TOXIN; CARCINOGENESIS; CELLS; 1,2-DIMETHYLHYDRAZINE; INFLAMMATION; PROGRESSION;
D O I
10.7717/peerj.15777
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer (CRC), which develops from the gradual evolution of tubular adenomas and serrated polyps in the colon and rectum, has a poor prognosis and a high mortality rate. In addition to genetics, lifestyle, and chronic diseases, intestinal integrity and microbiota (which facilitate digestion, metabolism, and immune regulation) could promote CRC development. For example, enterotoxigenic Bacteroides fragilis, genotoxic Escherichia coli (pks+ E. coli), and Fusobacterium nucleatum, members of the intestinal microbiota, are highly correlated in CRC. This review describes the roles and mechanisms of these three bacteria in CRC development. Their interaction during CRC initiation and progression has also been proposed. Our view is that in the precancerous stage of colorectal cancer, ETBF causes inflammation, leading to potential changes in intestinal ecology that may provide the basic conditions for pks+ E. coli colonization and induction of oncogenic mutations, when cancerous intestinal epithelial cells can further recruit F. nucleatum to colonise the lesion site and F. nucleatum may contribute to CRC advancement by primarily the development of cancer cells, stemization, and proliferation, which could create new and tailored preventive, screening and therapeutic interventions. However, there is the most dominant microbiota in each stage of CRC development, not neglecting the possibility that two or even all three bacteria could be engaged at any stage of the disease. The relationship between the associated gut microbiota and CRC development may provide important information for therapeutic strategies to assess the potential use of the associated gut microbiota in CRC studies, antibiotic therapy, and prevention strategies.
引用
收藏
页数:26
相关论文
共 50 条
  • [31] Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
    Vacante, Marco
    Ciuni, Roberto
    Basile, Francesco
    Biondi, Antonio
    BIOMEDICINES, 2020, 8 (11) : 1 - 19
  • [32] Colorectal Cancer Patients Have Four Specific Bacterial Species in Oral and Gut Microbiota in Common-A Metagenomic Comparison with Healthy Subjects
    Uchino, Yoshinori
    Goto, Yuichi
    Konishi, Yusuke
    Tanabe, Kan
    Toda, Hiroko
    Wada, Masumi
    Kita, Yoshiaki
    Beppu, Mahiro
    Mori, Shinichiro
    Hijioka, Hiroshi
    Otsuka, Takao
    Natsugoe, Shoji
    Hara, Eiji
    Sugiura, Tsuyoshi
    CANCERS, 2021, 13 (13)
  • [33] Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
    Yachida, Shinichi
    Mizutani, Sayaka
    Shiroma, Hirotsugu
    Shiba, Satoshi
    Nakajima, Takeshi
    Sakamoto, Taku
    Watanabe, Hikaru
    Masuda, Keigo
    Nishimoto, Yuichiro
    Kubo, Masaru
    Hosoda, Fumie
    Rokutan, Hirofumi
    Matsumoto, Minori
    Takamaru, Hiroyuki
    Yamada, Masayoshi
    Matsuda, Takahisa
    Iwasaki, Motoki
    Yamaji, Taiki
    Yachida, Tatsuo
    Soga, Tomoyoshi
    Kurokawa, Ken
    Toyoda, Atsushi
    Ogura, Yoshitoshi
    Hayashi, Tetsuya
    Hatakeyama, Masanori
    Nakagama, Hitoshi
    Saito, Yutaka
    Fukuda, Shinji
    Shibata, Tatsuhiro
    Yamada, Takuji
    NATURE MEDICINE, 2019, 25 (06) : 968 - +
  • [34] Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
    Okumura, Shintaro
    Konishi, Yusuke
    Narukawa, Megumi
    Sugiura, Yuki
    Yoshimoto, Shin
    Arai, Yuriko
    Sato, Shintaro
    Yoshida, Yasuo
    Tsuji, Shunya
    Uemura, Ken
    Wakita, Masahiro
    Matsudaira, Tatsuyuki
    Matsumoto, Tomonori
    Kawamoto, Shimpei
    Takahashi, Akiko
    Itatani, Yoshiro
    Miki, Hiroaki
    Takamatsu, Manabu
    Obama, Kazutaka
    Takeuchi, Kengo
    Suematsu, Makoto
    Ohtani, Naoko
    Fukunaga, Yosuke
    Ueno, Masashi
    Sakai, Yoshiharu
    Nagayama, Satoshi
    Hara, Eiji
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [35] Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer
    Wu, Qi-Long
    Fang, Xiao-Ting
    Wan, Xin-Xin
    Ding, Qing-Yong
    Zhang, Yan-Jun
    Ji, Ling
    Lou, Yong-Liang
    Li, Xiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (14) : 2018 - 2037
  • [36] Gut microbiota profiling variated during colorectal cancer development in mouse
    Liu, Jingjing
    Dong, Wei
    Zhao, Jian
    Wu, Jing
    Xia, Jinqiang
    Xie, Shaofei
    Song, Xiaofeng
    BMC GENOMICS, 2022, 23 (SUPPL 4)
  • [37] MEK5 overexpression is associated with the occurrence and development of colorectal cancer
    Diao, Dechang
    Wang, Lei
    Wan, Jin
    Chen, Zhiqiang
    Peng, Junsheng
    Liu, Huanliang
    Chen, Xinlin
    Wang, Wei
    Zou, Liaonan
    BMC CANCER, 2016, 16
  • [38] Gut microbiota profiling variated during colorectal cancer development in mouse
    Jingjing Liu
    Wei Dong
    Jian Zhao
    Jing Wu
    Jinqiang Xia
    Shaofei Xie
    Xiaofeng Song
    BMC Genomics, 23
  • [39] Extracellular Granzyme A Promotes Colorectal Cancer Development by Enhancing Gut Inflammation
    Santiago, Llipsy
    Castro, Marta
    Sanz-Pamplona, Rebeca
    Garzon, Marcela
    Ramirez-Labrada, Ariel
    Tapia, Elena
    Moreno, Victor
    Layunta, Elena
    Gil-Gomez, Gabriel
    Garrido, Marta
    Pena, Raul
    Lanuza, Pilar M.
    Comas, Laura
    Jaime-Sanchez, Paula
    Uranga-Murillo, Iratxe
    del Campo, Rosa
    Pelegrin, Pablo
    Camerer, Eric
    Martinez-Lostao, Luis
    Munoz, Guillermo
    Uranga, Jose A.
    Alcalde, Anabel
    Galvez, Eva M.
    Ferrandez, Angel
    Bird, Phillip, I
    Metkar, Sunil
    Arias, Maykel A.
    Pardo, Julian
    CELL REPORTS, 2020, 32 (01):
  • [40] Banxia Xiexin Decoction inhibits colitis-associated colorectal cancer development by modulating STAT3 signaling and gut microbiota
    Yue, Yinzi
    Su, Lianlin
    Wang, Yahui
    Li, Xiaoman
    Xiao, Xiaoyan
    Xie, Jin
    Yan, Shuai
    CHINESE HERBAL MEDICINES, 2025, 17 (02) : 380 - 391